- Prescription Drug Monitoring Program - Revisions
- Sponsored by
- The Speaker (By Request - Administration) and Delegates Adams, Afzali, Anderton, Aumann, Beitzel, Buckel, Carozza, Cassilly, Ciliberti, Cluster, Fisher, Flanagan, Folden, Ghrist, Hornberger, Impallaria, Jacobs, Kipke, Krebs, Long, Malone, Mautz, McComas, McConkey, McDonough, McKay, Metzgar, Miele, W. Miller, Morgan, O'Donnell, Otto, Parrott, Reilly, Rose, Saab, Shoemaker, Simonaire, Szeliga, Vogt, West, and B. Wilson
- In the House - Hearing 2/18 at 1:00 p.m.
- Fiscal and Policy Note
Requiring that specified authorized providers and prescribers be registered with the Prescription Drug Monitoring Program before obtaining a specified new or renewal registration or by July 1, 2017, whichever is sooner; requiring that specified pharmacists be registered with the Program by a certain date; requiring specified prescribers and pharmacists to request and assess specified drug monitoring data under specified circumstances; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2016
By Request of the Governor
|Date Posted||Document Name|
|1/29/2016||Text - First - Prescription Drug Monitoring Program - Revisions|
( 5-304 )
( 21-2A-01, 21-2A-02, 21-2A-03, 21-2A-04, 21-2A-04.1, 21-2A-04.2, 21-2A-05, 21-2A-06, 21-2A-07, 21-2A-08, 21-2A-09 )
Last Updated: 2/3/2020 2:29 PM